(Q33377581)
Statements
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 (English)
G Fountzilas
Hellenic Cooperative Oncology Group
H Gogas
H Linardou
E Briasoulis
D Pectasides
E Samantas
D Bafaloukos
G P Stathopoulos
M Karina
C Papadimitriou
D Skarlos
N Pisanidis
P Papakostas
E Tzorakoeleftherakis
K Dimitrakakis
P Makrantonakis
N Xiros
A Polichronis
I Varthalitis
C Karanikiotis
27 November 2007